Security
ORION BIOTECH OPPORTUNITIES CORP WT EXP · ORIAW
ORIAWOTCWarrantHistorical · closed May 18, 2023CIK 1847416Updated Nov 16, 2026
ORIAW price & chart
Historical security
This listing closed May 18, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 | Q1 2021 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| AssetsUSD | 201,834,778Source | 201,563,699Source | 201,119,800Source | 201,800,462Source | 201,124,000Source | 376,253Source | 203,332,786Source | 201,361,611Source |
| Current assets: | ||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 341,028Source | 780,418Source | 418,547Source | 880,699Source | 575,900Source | — | 265,717Source | 712,474Source |
| Assets, CurrentUSD | 633,224Source | 1,559,347Source | 821,002Source | 1,798,683Source | 1,095,281Source | — | 439,320Source | 1,353,033Source |
| LIABILITIES AND EQUITY | ||||||||
| LiabilitiesUSD | 8,122,140Source | 14,423,317Source | 8,327,420Source | 16,924,314Source | 10,260,976Source | — | 8,331,760Source | 15,116,882Source |
| Stockholders’ equity: | ||||||||
| Retained Earnings (Accumulated Deficit)USD | -7,389,416Source | -12,860,118Source | -7,406,918Source | -2,093,079Source | -9,137,476Source | -45,085Source | -7,792,939Source | -13,755,771Source |
| Stockholders' Equity Attributable to ParentUSD | -7,388,916Source | -12,859,618Source | -7,406,418Source | -15,123,852Source | -9,136,976Source | -20,085Source | -7,792,439Source | -13,755,271Source |
| Liabilities and EquityUSD | 201,834,778Source | 201,563,699Source | 201,119,800Source | 201,800,462Source | 201,124,000Source | 376,253Source | 203,332,786Source | 201,361,611Source |
| Current liabilities: | ||||||||
| Liabilities, CurrentUSD | 57,973Source | 82,917Source | 40,290Source | 97,781Source | 110,043Source | 396,338Source | 67,593Source | 81,631Source |
| Accounts Payable, CurrentUSD | 12,973Source | 6,587Source | 5,298Source | 14,516Source | 23,361Source | 22,000Source | 7,718Source | 11,631Source |
| Additional Financial Items | ||||||||
| Accrued Liabilities, CurrentUSD | 45,000Source | 76,330Source | 34,992Source | 83,265Source | 86,682Source | 276,265Source | 59,875Source | 70,000Source |
| Common Stock, Value, Issued | — | — | — | —Source | — | — | — | — |
| Additional Paid in Capital | — | — | — | —Source | — | —Source | — | — |
cash flow · annual statements
| Line item | Q4 2022 | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 2,264,234Source | — | -2,047,994Source | 4,618,295Source | — | -724,498Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Changes in operating assets and liabilities: | ||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | 11,730Source | -3,913Source | 11,631Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | -136,574Source | -376,757Source | -1,221,813Source |
| Cash flows from investing activities: | ||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | -200,000,000Source |
| Cash flows from financing activities: | ||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -70,000Source | 201,934,287Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 341,028Source | 780,418Source | 418,547Source | 880,698Source | 575,900Source | 265,717Source | 712,474Source |
| Additional Financial Items | ||||||||
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | — | -239,453Source | — | — | -239,453Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | -107,400Source | — | — | -107,400Source |
| General and Administrative ExpenseUSD | — | 175,461Source | 194,472Source | 174,526Source | 139,104Source | 256,164Source | 779,674Source | 553,689Source |
| Investment Income, InterestUSD | — | — | — | — | — | 20,141Source | 2,884,887Source | 8,578Source |
| Net Income (Loss) Attributable to ParentUSD | — | 920,258Source | 2,264,234Source | 1,929,356Source | -2,047,994Source | 4,618,295Source | 8,756,297Source | -724,498Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | 70,000Source | 4,467,640Source |
income statement · annual statements
| Line item | Q4 2022 | Q3 2022 | Q3 2021 | Q2 2022 | Q2 2021 | Q1 2022 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | -205,461Source | -224,472Source | -204,526Source | -153,620Source | -286,164Source | -899,674Source | -628,205Source |
| Net Income (Loss) Attributable to ParentUSD | — | 920,258Source | 2,264,234Source | 1,929,356Source | -2,047,994Source | 4,618,295Source | 8,756,297Source | -724,498Source |
| Additional Financial Items | ||||||||
| General and Administrative ExpenseUSD | — | 175,461Source | 194,472Source | 174,526Source | 139,104Source | 256,164Source | 779,674Source | 553,689Source |
| Investment Income, InterestUSD | — | — | — | — | — | 20,141Source | 2,884,887Source | 8,578Source |
| Other ExpensesUSD | — | — | — | — | — | 100,000Source | 100,000Source | 100,000Source |
| Earnings Per Share, Diluted | — | — | — | — | —Source | — | — | — |